Search

Search Constraints

You searched for: Author/Creator van Der Flier, Wiesje

Search Results

1. A mixed‐methods approach to establish clinically meaningful categories of impairment in instrumental activities of daily living: Human/Human trials: Other behavioral symptoms. (7th December 2020)

2. Amyloid pathology, but not vascular pathology, is associated with risk of incident dementia in non‐demented memory clinic participants: Neuroimaging: Neuroimaging predictors of cognitive decline. (7th December 2020)

3. Amyloid‐β deposition in cognitively normal oldest‐old is associated with cortical thinning and faster memory decline: Imaging correlates of cognition and biomarkers. (7th December 2020)

4. Amyloid‐β deposition in cognitively normal oldest‐old is associated with cortical thinning and faster memory decline: Neuroimaging: Neuroimaging predictors of cognitive decline. (7th December 2020)

5. An RCT to identify best practices for disclosure of amyloid imaging results in mild cognitive impairment: The ABIDE simulation study: Implementation of person‐centered care. (7th December 2020)

6. Associations of brain connectivity with disease progression and cognitive dysfunction in autosomal‐dominant Alzheimer disease depend on imaging modality: Neuroimaging / multi‐modal comparisons. (7th December 2020)

7. Associations of nutritional parameters with clinical progression in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's disease: The NUDAD project: Nutrition, the unrecognized determinant of Alzheimer's disease. (7th December 2020)

8. Attitudes towards genetic susceptibility testing for Alzheimer's disease dementia in cognitively normal adults: A survey study: Developing topics. (7th December 2020)

9. BDNF‐Met polymorphism on top of amyloid pathology predisposes for faster cognitive decline in cognitively normal elderly: The SCIENCe Project: Genetics/genetic factors of Alzheimer's disease. (7th December 2020)

10. Biomarker testing in MCI patients: Deciding who to tap: Biomarkers (non‐neuroimaging)/Prognostic utility. (7th December 2020)